Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | ML348@LNP-MAN, ML348 loaded lipid nanoparticle-mannose |
| Catalog Number | R-LNP-M01 |
| Alias | ML348@LNP-Mannose |
| Appearance | White or off-white powder or granules |
| Molecular Formula | N/A |
| Solubility | Soluble in organic solvents |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | drug delivery |
| Specification | 10mg:Inquiry 25mg:Inquiry 50mg:Inquiry |
| Description | ML348@LNP-MAN is a complex system constructed by combining the selective and reversible lysophospholipase 1 (LYPLA1) inhibitor ML348 with lipid nanoparticle (LNP) technology and equipped with mannose (MAN) targeting ligand. ML348 itself can inhibit LYPLA1 with an IC50 value of 210nM, and can also act on acyl protein thioesterase 1 (APT1), showing potential in related research such as Huntington's disease. LNP has a lipid bilayer structure, which can effectively wrap ML348, protect it from premature degradation, and help the drug cross the biological membrane barrier with its good biocompatibility. The introduction of MAN ligand gives the system targeting properties and can bind to specific mannose receptors on the cell surface, accurately delivering ML348 to target cells, improving the effectiveness of the drug, and has application prospects in the field of disease treatment and related mechanism research. |